A detailed history of Gts Securities LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 2,151 shares of CRL stock, worth $354,915. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,151
Previous 1,616 33.11%
Holding current value
$354,915
Previous $318,000 124766.35%
% of portfolio
0.02%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

BUY
$178.58 - $220.69 $95,540 - $118,069
535 Added 33.11%
2,151 $397 Million
Q3 2024

Nov 13, 2024

BUY
$187.96 - $245.29 $303,743 - $396,388
1,616 New
1,616 $318,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.39B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.